The FDA sent Novo Nordisk a warning over unreported weight loss drug side effects

The Food and Drug Administration issued a warning letter to Novo Nordisk earlier this month, citing the company’s failure to report serious suspected side effects from its drugs to the agency within required deadlines.

The letter followed an inspection of a Novo Nordisk facility conducted between Jan. 13 and Feb. 7, 2025, the FDA said. The agency found that the company failed to submit reports of serious and unexpected adverse drug experiences within the required 15-day window and failed to adequately investigate those reports.

Related Content

Lawmakers are turning on prediction markets over state secrets

Costco’s growth machine is still running hot

Among the specific cases the FDA identified: a patient who was disabled after experiencing a stroke while taking liraglutide; a patient death involving a male who had received semaglutide, where Novo Nordisk failed to capture a patient identifier and did not submit the report; and a consumer who reported suicidal ideation while taking semaglutide, a case that sat in “medical review” status for nearly two months before being submitted to the FDA. The FDA did not conclude whether any of the deaths were linked to the drugs, according to The Wall Street Journal.

A second death — a patient taking semaglutide whose physician reported depression and suicide — had not been submitted to the FDA as of the date the warning letter was issued, the agency said.

Semaglutide is the active ingredient in Novo Nordisk’s blockbuster weight loss drugs Ozempic and Wegovy.

The FDA said Novo Nordisk’s written procedures allowed adverse event reports to be rejected if a reporter believed the event was unrelated to the product — a standard inconsistent with federal regulations, which require reporting of any adverse event associated with a drug’s use in humans regardless of perceived causation. The agency also found that cases were improperly invalidated due to missing patient identifiers even when those identifiers were present in source documents.

“Your explanations, when taken into consideration with the violations described above and your failure to adequately address your noncompliance, suggest systemic failures with your surveillance, receipt, evaluation, and reporting of ADEs to FDA,” the agency wrote.

The FDA acknowledged corrective steps Novo Nordisk has taken since the inspection but said the company’s responses lacked sufficient detail to confirm that future violations would be prevented. Novo Nordisk has 15 business days to inform the agency of actions it will take. Failure to respond adequately may lead to regulatory action, the FDA said.

Novo Nordisk said it has been in regular communication with the FDA about its corrective action plan and is working to respond to the letter. “We are confident that we will be able to respond to the requests in the Warning Letter to the Agency’s full satisfaction,” the company said, according to The Wall Street Journal. The company added that the letter does not reach conclusions about the quality or safety of its treatments.

The warning covers products with active ingredients including semaglutide, liraglutide, nedosiran sodium, and estradiol, according to the FDA.

📬 Sign up for the Daily Brief

Our free, fast and fun briefing on the global economy, delivered every weekday morning.

Sign me up

10 Stocks in the Defense Spending BoomSee Which 10 Defense Stocks Show Strong Growth Signals.Seeking Alpha |

SponsoredSponsored

Explore

Undo

医療保障タイプ入院１日目から最高180日分保障！日帰り入院でも日額10,000円／こくみん共済 coop全国労働者共済生活協同組合連合会 |

SponsoredSponsored

詳細

Undo

【東京都】神絵祭-翔- |　神絵師 × 職人技術—。人気作品が目白押し、ファン必見の展示販売会！| 絵画展示販売会神絵祭_東京 |

SponsoredSponsored

もっと見る

Undo

「もしも」の保障だけじゃない？いつもの暮らしや大切なライフイベントに役立つサービスが使い放題。／こくみん共済 coop全国労働者共済生活協同組合連合会 |

SponsoredSponsored

詳細

Undo

Buy The Dip: 2 Of The Best Undervalued 8%-10% Yields I’ve SeenMost investors chase growth. These two overlooked income plays offer 8–10% yields at prices that still make sense.Seeking Alpha |

SponsoredSponsored

Read More

Undo

今すぐ冒険を2倍に8つの都市への往復便を今すぐ予約。追加料金なし、税金のみでご利用いただけます。マレーシア航空 |

SponsoredSponsored

今すぐ予約

Undo

60歳になって聞き返すことが増えた私の最適解！ワンタッチ操作の集音器Olive Union |

SponsoredSponsored

続きを読む

Undo

Many women here want a senior dating — join in.While You Wait - They’re Chatting [Try It]GoldenAgeSouls |

SponsoredSponsored

Click Here

Undo

Stop Waiting Start DatingLooking for single women? Join us!Asiavibe |

SponsoredSponsored

Read More

Undo

1000万人以上が避難。なぜスーダンの人道危機は「見過ごされる」のか？難民を助ける会 |

SponsoredSponsored

Undo

50代「もっと早く知りたかった…」6億円売れた履いて歩くだけの美姿勢の秘訣いつもの靴を変えて歩くだけ！体幹が目覚め健康的なカラダづくりをサポート。運動が苦手でもラクラク体幹ダイエット！amepla |

SponsoredSponsored

詳細

Undo

「食べないで！」心臓専門医が警告する最悪の食品12選NewSphere |

SponsoredSponsored

Undo

Play this game for 1 minute and see why everyone is crazy about itNo Installation. Play for free.planetcapture.io |

SponsoredSponsored

Undo

Donald Trump Jr. et Eric Trump soutiennent la société de drones PowerusQuartz

Undo

The woman who sued Donald Trump alleging child rape has called off her press conferenceQuartz

Undo

なぜ彼女は夫を残し逃げたのか？世界が注目しないスーダンで、いま起きている"戦地"の裏側難民を助ける会 |

SponsoredSponsored

Undo

革命的な爪切りで、ケアがより安全で簡単に！ロングハンドルの爪切りWMET |

SponsoredSponsored

今すぐ購入

Undo

Paul Gascoigne’s Actual House Left Us With No Words - Take A LookToday’s NYC |

SponsoredSponsored

Undo

社会実装が近づく自動運転、周辺の「社会システムづくり」に広がるビジネス機会とは？日経BP × ひとと世界をつなぐ技術の未来 |

SponsoredSponsored

Undo

「窓」が体験を生み出すインターフェースに変わる！裸眼のままで車外が3D仮想空間に日経BP × ひとと世界をつなぐ技術の未来 |

SponsoredSponsored

Undo

MOST POPULAR

The safest vehicles under $35,000, according to Consumer ReportsQuartz

Undo

MOST POPULAR

The 10 best compact cars, according to Car and DriverQuartz

Undo

1位になんと…！「移住したい国ランキング」NewSphere |

SponsoredSponsored

Undo

Top AI Income Generators You Probably Haven’t Heard of YetAI Income Generators | Search Ads |

SponsoredSponsored

Learn More

Undo

She Was Everyone’s Dream Girl In 90’s, This Is Her RecentlyCash Roadster |

SponsoredSponsored

Undo